The evolving role of the specialist in the diagnosis and management of the patient with OAB

European Urology, Supplement

Volumn 1, Issue 4, 2002, Pages 17-22

  Bosch, J L H Ruud ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diagnosis; Overactive bladder (OAB); Treatment

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; PROPIVERINE; TOLTERODINE; TROSPIUM CHLORIDE;

AGE DISTRIBUTION; ANTICHOLINERGIC EFFECT; BEHAVIOR THERAPY; CONFERENCE PAPER; CONSTIPATION; DECISION MAKING; DIAGNOSTIC TEST; DRUG EFFICACY; GENDER; HUMAN; MEDICAL SPECIALIST; NEUROMODULATION; NOCTURIA; OVERACTIVE BLADDER; PATIENT SATISFACTION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; QUALITY OF LIFE; RISK FACTOR; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT PLANNING; URGE INCONTINENCE; URINARY FREQUENCY; URODYNAMICS; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 0036664776     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(02)00044-1     Document Type: Conference Paper

References (35)

1. Abrams P, Wein AJ. Introduction: Overactive bladder and its treatments. Urology 2000;55(5A):1-2.
2. Blaivas JG. Defining words: Overactive bladder. Neurourol Urodyn 1999;18:417-8.
3. Donovan J, Naughton M, Gotoh M, Corcos J, Jackson S, Kelleher C, et al. Symptom and quality of life assessment. In: Abrams P, Khoury S, Wein A, editors. Incontinence, 1st International Consultation on Incontinence. Health Publication Ltd., 1999.
4. Abrams P, Wein A, Schussler B, Kawabi K, Bump R, Melchior H, et al. Recommendations of the international scientific committee: The evaluation and treatment of urinary incontinence. In: Abrams P. Khoury S, Wein A, editors. Incontinence, 1st International Consultation on Incontinence. Health Publication Ltd., 1999.
5. Bosch JLHR. Instability of the bladder: Pathophysiology unknown? A synopsis of clinical points of interest. Neurourol Urodyn 1990;9:563-5.
6. Wall LL, Hewitt JK. Urodynamic characteristics of women with complete posthysterectomy vaginal vault prolapse. Urology 1994;44(3):336-42.
7. Rosenzweig BA, Pushkin S, Blumenfeld D, Bhatia NN. Prevalence of abnormal urodynamic test results in continent women with severe genitourinary prolapse. Obstet Gynecol 1992;79:539-42.
8. Nguyen JK, Bhatia NN. Resolution of motor urge incontinence after surgical repair of pelvic organ prolapse. J Urol 2001;166:2263-6.
9. Hextall A, Bidmead J, Cardozo L, Hooper R. Hormonal influences on the human female lower urinary tract: A prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation. Neurourol Urodyn 1999;18:363-4.
10. Jensen JK, Nielsen FR, Ostergard DR. The role of patient history in the diagnosis of urinary incontinence. Obstet Gynecol 1994;83:904-10.
11. Digesu GA, Salvatore S, Cardozo L, Robinson D, Khullar V. Symptomatic diagnosis of the overactive bladder: Is it helpful? Neurourol Urodyn 2000;19:381-2.
12. Schrepferman CG, Griebling TL, Nygaard IE, Kreder KJ. Resolution of urge symptoms following sling cystourethropexy. J Urol 2000;164:1628-31.
13. Chapple CR. Muscarinic receptor antagonists in the treatment of overactive bladder. Urology 2000;55(Suppl 5A):33-46.
14. Fantl JA, Newman DK, Colling J, DeLancey JOL, Keeys C, Loughery R, et al. Urinary incontinence in adults: Acute and chronic management. Clinical Practice Guideline No. 2, 1996 update. AHCPR Publication No. 96-0682. Rockville (MD): US Department of Health and Human Services, Agency for Health Care Policy and Research, March 1996.
15. Zeegers AGM, Kieswetter H, Kramer AEJL, Jonas U. Conservative therapy of frequency, urgency and urge incontinence: A double-blind clinical trial of flavoxate hydrochloride, oxybutinin chloride, emepronium bromide and placebo. World J Urol 1987;5:57.
16. Stöhrer M, Bauer P, Gianetti BM, Richter R, Burgdorfer H, Murtz G. Effect of trospium chloride on urodynamic parameters in patients with detrusor hypereflexia due to spinal cord injuries: A multicenter placebo controlled double-blind trial. Urol Int 1991;47:138-43.
17. Wehnert J, Sage S. Therapie der Blaseninstabilität und Urge-inkontinenz mit Propiverin Hydrochlorid und Oxybutinin Chlorid - Eine randomisierte Cross-over-vergleichsstudie. Akt Urol 1992;23:7-11.
18. Millard R, Tuttle J, Moore K, Susset J, Clarke B, Dwyer P, Davis PE. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J Urol 1999;161:1551-5.
19. Kelleher CJ, Cardozo LD, Khullar V, Salavatore S. A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997;104:988-93.
20. Wilson PD, Bo K, Bourcier A, Hay-Smith J, Staskin D, Nygaard I, et al. Conservative management in women. In: Abrams P, Khoury S, Wein A, editors. Incontinence, 1st International Consultation on Incontinence. Health Publication Ltd., 1999.
21. Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 2000;48(4):370-4.
22. Jorgensen L, Lose G, Molsted-Pedersen L. Vaginal repair in female motor urge incontinence. Eur Urol 1987;13:382-5.
23. Groen J, Bosch JLHR. Neuromodulation techniques in the treatment of the overactive bladder. Br J Urol Int 2001;87(8):723-31.
24. Bosch JLHR, Groen J. Sacral nerve neuromodulation in the treatment of patients with refractory motor urge incontinence: Long-term results of a prospective longitudinal study. J Urol 2000;163:1219-22.
25. Leng WW, Blalock HJ, Fredriksson WH, English SF, McGuire EJ. Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol 1999;161:758-63.
26. Swami KS, Feneley RCL, Hammonds JC, Abrams P. Detrusor myectomy for detrusory overactivity: A minimum 1-year follow-up. Br J Urol 1998;81:68-72.
27. Flynn R, Appanna T, Stephenson TP. Clinical experience with radical detrusor myectomy. Br J Urol Int 1999;83(Suppl 4):P31.
28. Tweedle JR, Mahesh-Kumar P, Ramsey IN, Conn IG. The detrusor myectomy procedure for idiopathic detrusor instability: A clinical and urodynamic assessment. Br J Urol Int 1999;83(Suppl 4):P78.
29. Mundy AR, Stephenson TP. "Clam" ileocystoplasty for the treatment of refractory urge incontinence. Br J Urol 1985;57:641-6.
30. Kockelbergh RC, Tan JBL, Bates CP, Bishop MC, Dunn M, Lemberger RJ. Clam enterocystoplasty in general urological practice. Br J Urol 1991;68:38-41.
31. McInerney PD, DeSouza N, Thomas PJ, Mundy AR. The role of urodynamic studies in the evaluation of patients with augmentation cystoplasties. Br J Urol 1995;76:475-8.
32. Hasan ST, Marshall C, Robson WA, Neal DE. Clinical outcome and quality of life following enterocystoplasty for idiopathic detrusor instability and neurogenic bladder dysfunction. Br J Urol 1995;76:551-7.
33. Flood HD, Sumeeta JM, O'Connell HE, Ritchey MJ, Bloom DA, McGuire EJ. Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn 1995;14:297-309.
34. Awad SA, Al-Zahrani A, Gajewski JB, Bourque-Kehoe AA. Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol 1998;81:569-73.
35. Chapple CR, Bosch JLHR, Hanus T. Female incontinence. Eur Urol 2000;38(4):535-46.